Merck
Merck to cut jobs and costs as demand for Gardasil in China remains weak
The cost cuts include US$1.7 billion in annual savings from the elimination of certain administrative, sales and R&D positions
Merck nears US$10 billion deal for London-based lung therapy firm Verona, FT reports
The deal values Verona at about US$107 per American depository share
Merck held talks to buy biotech MoonLake for over US$3 billion: FT
MERCK has held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than US$3 billion, the Financial Times reported on Monday, citing three people familiar with the matter.
China’s WuXi Biologics to sell vaccine facility to Merck for US$500 million
WUXI Biologics Cayman will sell a vaccine facility in Ireland to Merck for about US$500 million as the Chinese company seeks to enhance its margins while continuing to navigate geopolitical tensions.
Merck snags Chinese obesity drug in nearly US$2 billion deal
MERCK snagged a potential drug in the burgeoning market for obesity medications in a deal worth as much as US$2 billion.
Merck snags Chinese cancer drug for up to US$3.3 billion
MERCK & Co licenced an experimental cancer antibody from a closely held Chinese company in a deal worth US$588 million upfront, plus as much as US$2.7 billion in milestone payments.
Merck narrows sales outlook with Gardasil lagging in China
MERCK lowered the top end of its full-year sales guidance after demand for its HPV vaccine fell for a second straight quarter in China.
Germany’s Merck open to more M&A for its Life Science division
GERMAN science and technology group Merck is open to more acquisitions for its Life Science business after announcing in May it would buy Mirus Bio for US$600 million, it said ahead of its Capital Mar...
Germany's Merck to open semiconductor base in China
GERMAN supplier of chemicals and materials used in making semiconductors, KGaA , said on Tuesday (May 31) it had signed a contract to open a semiconductor base in the Chinese city of Zhangjiagang, des...
